1. Home
  2. TVTX vs PRK Comparison

TVTX vs PRK Comparison

Compare TVTX & PRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • PRK
  • Stock Information
  • Founded
  • TVTX 2008
  • PRK 1908
  • Country
  • TVTX United States
  • PRK United States
  • Employees
  • TVTX N/A
  • PRK N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • PRK Major Banks
  • Sector
  • TVTX Health Care
  • PRK Finance
  • Exchange
  • TVTX Nasdaq
  • PRK Nasdaq
  • Market Cap
  • TVTX 2.5B
  • PRK 2.8B
  • IPO Year
  • TVTX N/A
  • PRK N/A
  • Fundamental
  • Price
  • TVTX $29.05
  • PRK $159.33
  • Analyst Decision
  • TVTX Strong Buy
  • PRK Hold
  • Analyst Count
  • TVTX 15
  • PRK 2
  • Target Price
  • TVTX $34.86
  • PRK $170.00
  • AVG Volume (30 Days)
  • TVTX 1.8M
  • PRK 54.4K
  • Earning Date
  • TVTX 10-30-2025
  • PRK 10-20-2025
  • Dividend Yield
  • TVTX N/A
  • PRK 2.68%
  • EPS Growth
  • TVTX N/A
  • PRK 22.52
  • EPS
  • TVTX N/A
  • PRK 10.28
  • Revenue
  • TVTX $333,865,000.00
  • PRK $530,594,000.00
  • Revenue This Year
  • TVTX $83.23
  • PRK $10.39
  • Revenue Next Year
  • TVTX $41.49
  • PRK $2.43
  • P/E Ratio
  • TVTX N/A
  • PRK $15.52
  • Revenue Growth
  • TVTX 87.94
  • PRK 11.59
  • 52 Week Low
  • TVTX $12.91
  • PRK $137.97
  • 52 Week High
  • TVTX $28.85
  • PRK $207.99
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 73.62
  • PRK 47.60
  • Support Level
  • TVTX $26.79
  • PRK $156.97
  • Resistance Level
  • TVTX $28.24
  • PRK $160.43
  • Average True Range (ATR)
  • TVTX 1.02
  • PRK 3.87
  • MACD
  • TVTX -0.01
  • PRK 0.32
  • Stochastic Oscillator
  • TVTX 100.00
  • PRK 71.06

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About PRK Park National Corporation

Park National Corp is a diversified financial services company based in Newark, Ohio, consisting of 11 community banking divisions with more than 100 offices in Ohio and Kentucky. Park National provides banking and other financial services to consumers and businesses.

Share on Social Networks: